Skip to main content
Advanced Technical IVT

lipoprotein(a)

Pronunciation: LIE-poh-pro-teen A

A genetic variant of LDL containing apolipoprotein(a), associated with increased cardiovascular risk when elevated.

Full Definition

Lipoprotein(a), abbreviated as Lp(a), is a lipoprotein particle consisting of an LDL-like particle covalently bound to apolipoprotein(a). Lp(a) levels are primarily determined by genetics and remain relatively stable throughout life, unlike other lipoproteins that respond to diet and medications. Elevated Lp(a) levels (>50 mg/dL or >125 nmol/L) are associated with increased risk of atherosclerotic cardiovascular disease and calcific aortic stenosis. Current lipid-lowering therapies have minimal effect on Lp(a), though newer therapies specifically targeting Lp(a) are in development.

Usage

Usage note: Use parentheses around the 'a'. Lp(a) is acceptable abbreviation in clinical notes.

In Context

  • "Elevated lipoprotein(a) at 85 mg/dL explains the patient's premature coronary disease." — Risk factor analysis
  • "Lp(a) screening revealed a significantly elevated level requiring enhanced risk assessment." — Laboratory interpretation

Also known as

Lp(a)

Don't confuse with

LDL-C apolipoprotein B

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON